A key Senate Republican who has long scrutinized safety-net hospitals for possible misuse of the 340B drug discount program is turning his attention to potential missteps by the drug industry and has asked two drug makers to get back to him by Wednesday (Oct. 9) regarding allegations they withheld discounts.
Quoted from InsideHealthPolicy.com